Placental dysfunction in Suramin-treated rats – a new model for pre-eclampsia
- 31 May 2005
- Vol. 26 (5) , 410-418
- https://doi.org/10.1016/j.placenta.2004.07.009
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Evaluation of a rat model of preeclampsia for HELLP syndrome characteristicsJournal of the Society for Gynecologic Investigation, 2003
- Administration of Nω-?-Arginine Methyl Ester (L-NAME) impairs endothelium-dependent relaxation in gravid but not nongravid ratsJournal of the Society for Gynecologic Investigation, 2003
- Oxidized and free whole blood thiols in preeclampsiaObstetrics & Gynecology, 2001
- Increased circulating lipid peroxides in severe preeclampsia activate NF‐κΒ and upregulate ICAM‐1 in vascular endothelial cellsThe FASEB Journal, 2000
- Placental isoprostane is significantly increased in preeclampsiaThe FASEB Journal, 2000
- 8-Iso-Prostaglandin F 2α Reduces Trophoblast Invasion and Matrix Metalloproteinase ActivityHypertension, 2000
- Maternal renal artery blood flow velocimetry in normal and hypertensive pregnanciesActa Obstetricia et Gynecologica Scandinavica, 1996
- Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic ratsTeratology, 1988
- Suramin in the treatment of AIDS: Mechanism of actionAntiviral Research, 1987
- Evidence that suramin and aurothiomalate are teratogenic in rat by disturbing yolk sac-mediated embryonic protein nutritionChemico-Biological Interactions, 1986